Stock RCKT ROCKET PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Rocket Pharmaceuticals, Inc.

Equities

RCKT

US77313F1066

Real-time Estimate Cboe BZX
Other stock markets
 19:58:44 28/05/2024 BST 		5-day change 1st Jan Change
20.72 USD -3.24% Intraday chart for Rocket Pharmaceuticals, Inc. -7.48% -31.06%
05-16 Transcript : Rocket Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
05-10 UBS Adjusts Rocket Pharmaceuticals Price Target to $51 From $54, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ROCKET PHARMACEUTICALS, INC. Stock Rocket Pharmaceuticals, Inc.
 1.94B - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 22.1B -
GENMAB A/S Stock Genmab A/S
 18.34B
  1. Stock Market
  2. Equities
  3. RCKT Stock
  4. Charts Rocket Pharmaceuticals, Inc.
  5. Sector Chart